Copyright
©The Author(s) 2015.
World J Gastroenterol. Jan 7, 2015; 21(1): 301-310
Published online Jan 7, 2015. doi: 10.3748/wjg.v21.i1.301
Published online Jan 7, 2015. doi: 10.3748/wjg.v21.i1.301
Table 2 Clinical and laboratory data of patients who had reduced steatosis by two degrees (n = 13)
| Parameter | Before diet | After diet | P value | ||
| Mean ± SD | Median (IQR) | Mean ± SD | Median (IQR) | ||
| Age (yr) | 53.44 ± 13.65 | 55 (14) | 53.44 ± 13.65 | 55 (14) | - |
| Body mass index (kg/m²) | 33.33 ± 5.32 | 34 (6.24) | 29.32 ± 3.83 | 30.62 (5.21) | P < 0.055 |
| Aspartatetransaminase (U/L) | 33 ± 11.7 | 30 (15) | 21.67 ± 7.35 | 19 (3) | P < 0.01 |
| Alaninetransaminase (U/L) | 42.2 ± 27.75 | 33 (14) | 24.9 ± 19.74 | 20 (8) | P < 0.01 |
| Gammaglutamyltrasferase (U/L) | 60.9 ± 74.87 | 34 (32) | 42 ± 51.39 | 28 (15) | NS |
| Triacylglycerols (mg/dL) | 141.8 ± 61.33 | 151 (77) | 113.4 ± 60 | 100 (72) | NS |
| Cholesterol (mg/dL) | 209.8 ± 47 | 214 (17) | 191.6 ± 58.65 | 196 (38) | P < 0.055 |
| High density lipoprotein (mg/dL) | 52.2 ± 14.43 | 48 (20) | 55.5 ± 18.9 | 52 (21) | NS |
| Low density lipoprotein (mg/dL) | 129 ± 42.9 | 124 (27) | 113.2 ± 52.83 | 119 (39) | NS |
| Glucose (mg/mL) | 104.8 ± 10.4 | 102 (10) | 105.4 ± 14.05 | 100 (17) | NS |
| Insulin (U/mL) | 8 ± 4.65 | 8.8 (7.7) | 5.95 ± 4.35 | 4.8 (5.5) | P < 0.05 |
| HOMA-IR | 2.11 ± 1.27 | 1.93 (2.12) | 1.58 ± 1.20 | 1.28 (1.94) | P < 0.05 |
- Citation: Maciejewska D, Drozd A, Ossowski P, Ryterska K, Jamioł-Milc D, Banaszczak M, Raszeja-Wyszomirska J, Kaczorowska M, Sabinicz A, Stachowska E. Fatty acid changes help to better understand regression of nonalcoholic fatty liver disease. World J Gastroenterol 2015; 21(1): 301-310
- URL: https://www.wjgnet.com/1007-9327/full/v21/i1/301.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i1.301